IPS Stock Analysis: Ipsos | PA
Consulting Services | PA, France | Market Cap: 1.463m EUR | 12M Return: -10.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.16M
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ipsos SA is a Paris-headquartered research firm founded in 1975 that delivers survey-based research services to corporate and institutional clients across Europe, the Middle East, Africa, the Americas, and Asia-Pacific. Its work spans the full information production chain, covering data collection, processing, analysis, reporting, and activation, supported by online, mobile, and device-agnostic survey tools, qualitative research, and a self-service platform called Ipsos.Digital. The company also runs specialty practices in audience measurement, brand tracking, customer experience, healthcare, public affairs, automotive, innovation, and behavioral science and neuroscience, while increasingly embedding artificial intelligence, machine learning, and data science into its analytics offerings through its Ipsos Knowledge Centre.
The firm operates in the highly fragmented global market research and consulting services industry, competing with peers such as NielsenIQ, Kantar, GfK, and the in-house research departments of large advertising holding companies. Its revenue model is largely project-based, with clients in sectors like consumer goods, healthcare, media, and automotive paying for customized research deliverables and ongoing tracking programs rather than standardized products.
- AI tools compress traditional survey labor costs and margins
- EMEA corporate research budgets remain under pressure from macro slowdown
- Dollar weakness and selective M&A shape reported revenue trajectory
| Net Income: 160.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.29 > 1.0 |
| NWC/Revenue: 20.52% < 20% (prev 5.04%; Δ 15.48% < -1%) |
| CFO/TA 0.10 > 3% & CFO 300.1m > Net Income 160.0m |
| Net Debt (483.1m) to EBITDA (329.0m): 1.47 < 3 |
| Current Ratio: 1.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.8m) vs 12m ago -1.41% < -2% |
| Gross Margin: 38.17% > 18% (prev 46.48%; Δ -8.31% > 0.5%) |
| Asset Turnover: 64.99% > 50% (prev 83.76%; Δ -18.77% > 0%) |
| Interest Coverage Ratio: 7.89 > 6 (EBIT TTM 261.7m / Interest Expense TTM 33.2m) |
| A: 0.13 (Total Current Assets 1.13b - Total Current Liabilities 731.7m) / Total Assets 3.08b |
| B: 0.06 (Retained Earnings 186.6m / Total Assets 3.08b) |
| C: 0.09 (EBIT TTM 261.7m / Avg Total Assets 3.00b) |
| D: 1.04 (Book Value of Equity 1.57b / Total Liabilities 1.51b) |
| Altman-Z'' = 2.73 = A |
| DSRI: 1.23 (Receivables 724.0m/736.2m, Revenue 1.95b/2.44b) |
| GMI: 1.22 (GM 46.48% / 38.17%) |
| AQI: 1.02 (AQ_t 0.58 / AQ_t-1 0.57) |
| SGI: 0.80 (Revenue 1.95b / 2.44b) |
| TATA: -0.05 (NI 160.0m - CFO 300.1m) / TA 3.08b) |
| Beneish M = -2.77 (Cap -4..+1) = A |
As of July 15, 2026, the stock is trading at EUR 35.36 with a total of 72,114 shares traded. Over the past week, the price has changed by +2.85%, over one month by -3.02%, over three months by -1.33% and over the past year by -10.64%.
Current recommended Stop Loss: 34.20 (which is 3.3% or 1.2 ATR below the current price).
Ipsos has no consensus analysts rating.
P/E Trailing = 8.1686
P/E Forward = 6.12
P/S = 0.5794
P/B = 0.9332
P/EG = 1.4433
Revenue TTM = 1.95b EUR
EBIT TTM = 261.7m EUR
EBITDA TTM = 329.0m EUR
Long Term Debt = 507.8m EUR (from longTermDebt, last quarter)
Short Term Debt = 48.4m EUR (from shortTermDebt, last quarter)
Debt = 800.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 139.1m
Net Debt = 483.1m EUR (calculated: Debt 800.6m - CCE 317.6m)
Enterprise Value = 1.95b EUR (1.46b + Debt 800.6m - CCE 317.6m)
Interest Coverage Ratio = 7.89 (Ebit TTM 261.7m / Interest Expense TTM 33.2m)
EV/FCF = 12.88x (Enterprise Value 1.95b / FCF TTM 151.1m)
FCF Yield = 7.76% (FCF TTM 151.1m / Enterprise Value 1.95b)
FCF Margin = 7.76% (FCF TTM 151.1m / Revenue TTM 1.95b)
Net Margin = 8.21% (Net Income TTM 160.0m / Revenue TTM 1.95b)
Gross Margin = 38.17% ((Revenue TTM 1.95b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 25.42% (prev 68.39%)
Tobins Q-Ratio = 0.63 (Enterprise Value 1.95b / Total Assets 3.08b)
Interest Expense / Debt = 4.14% (Interest Expense 33.2m / Debt 800.6m)
Taxrate = 25.92% (56.5m / 217.8m)
NOPAT = 193.9m (EBIT 261.7m * (1 - 25.92%))
Current Ratio = 1.55 (Total Current Assets 1.13b / Total Current Liabilities 731.7m)
Debt / Equity = 0.51 (Debt 800.6m / totalStockholderEquity, last quarter 1.57b)
Debt / EBITDA = 1.47 (Net Debt 483.1m / EBITDA 329.0m)
Debt / FCF = 3.20 (Net Debt 483.1m / FCF TTM 151.1m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.34% (Net Income 160.0m / Total Assets 3.08b)
RoE = 10.71% (Net Income TTM 160.0m / Total Stockholder Equity 1.49b)
RoCE = 13.07% (EBIT 261.7m / Capital Employed (Equity 1.49b + L.T.Debt 507.8m))
RoIC = 8.44% (NOPAT 193.9m / Invested Capital 2.30b)
WACC = 5.74% (E(1.46b)/V(2.26b) * Re(7.21%) + D(800.6m)/V(2.26b) * Rd(4.14%) * (1-Tc(0.26)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.76 | Cagr: -1.53%
[DCF] Terminal Value 73.10% ; FCFF base≈197.9m ; Y1≈173.5m ; Y5≈140.2m
[DCF] Fair Price = 42.14 (EV 2.25b - Net Debt 483.1m = Equity 1.77b / Shares 41.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: -75.68 | Revenue CAGR: -9.28% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=5.30 | Chg30d=+2.38% | Revisions=+0% | GrowthEPS=-3.7% | GrowthRev=+1.3%
EPS next Year (2027-12-31): EPS=5.68 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+7.1% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: +0% (up=0, down=0)